Liver Disease and Other Systemic Diseases

ConditionsLiver Diseases Humans Progression Carcinogenesis Fatty Liver Disease Hepatitis C Hepatitis B Hepatocellular Carcinoma Liver Cirrhoses Treatment Outcome

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-99

SponsorTaipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

About this trial

Examine the association of chronic liver diseases (including hepatitis B, hepatitis C, alcoholic liver disease, fatty liver, liver cirrhosis, and hepatocellular carcinoma) with other systemic diseases by retrospectively analyzing the data from the Hospital Database of Buddhist Tzu Chi Medical Foundation.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Individuals who visited the gastroenterology clinics of the Tzu Chi Hospitals, Buddhist Tzu Chi Medical Foundation

Disqualifiers

Age younger than 18 or older than 99 years

Trial population

Data collected from the Hospital Database of Buddhist Tzu Chi Medical Foundation

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

The incidence of a new diagnosis of hepatocellular carcinoma (HCC)

The new diagnosis of HCC is assessed every 3 months by abdominal sonography, and every 6 months with tumor markers (e.g. AFP), and confirmed by dynamic CT or MRI or pathological examination.

Time frame

From the date of enrollment until the date of first documented diagnosis of HCC, assessed up to 120 months.

The incidence of a new diagnosis of any event of liver cirrhosis complications

Liver cirrhosis complications include ascites, esophageal or gastric varices bleeding, hepatorenal syndrome, spontaneous bacterial peritonitis, hepatic encephalopathy, hepatic pulmonary syndrome, liver failure (Child-Pugh score B or C), or liver transplant, that are assessed every 3 months clinically. A new diagnosis of any event of liver cirrhosis complications is a new documented any of the above liver cirrhosis complications, whichever came first.

Time frame

From the date of enrollment until the date of first documented any event of liver cirrhosis complications, or date of death from any cause, whichever came first, assessed up to 120 months.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

Lead sponsor

Dalin Tzu Chi General Hospital

Collaborator

Source ClinicalTrials.gov

Apply now